MxT Biotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

MxT Biotech General Information

Description

Developer of microfluid-based intracellular material delivery designed to offer gene-editing services and automated process equipment. The company offers cell therapy products like mecha operators, which are non-viral-based intracellular mass transfer platforms, enabling professionals to deliver genes and nucleic acids into cells by creating gaps in the cell and nuclear membranes using the flow generated in microtubules.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 48, Ttukseom-ro 17ga-gil
  • Seongdong-gu
  • Seoul, 04785
  • South Korea
+82
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 48, Ttukseom-ro 17ga-gil
  • Seongdong-gu
  • Seoul, 04785
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MxT Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
6. Accelerator/Incubator 04-Jul-2023 Completed Generating Revenue
5. Early Stage VC (Series A) 15-May-2022 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
3. Seed Round 15-Jul-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 03-Mar-2021 Completed Generating Revenue
To view MxT Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MxT Biotech Patents

MxT Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025088687-A Intracellular substance transport platform of droplet base Active 30-Nov-2023
US-20250177984-A1 Platform for intracellular delivery using droplet microfluidics Pending 30-Nov-2023
EP-4324926-A1 Intracellular delivery platform Inactive 12-Apr-2021
EP-4324926-A4 Intracellular delivery platform Inactive 12-Apr-2021
US-20240158729-A1 Intracellular delivery platform Pending 12-Apr-2021 C12M35/04
To view MxT Biotech’s complete patent history, request access »

MxT Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MxT Biotech Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
IBK Changgong Accelerator/Incubator
Tech Incubator Program for Startup Accelerator/Incubator
BNK Venture Capital Venture Capital Minority
DAYLI Partners Venture Capital Minority
Hyundai Investment Partners Asset Manager Minority
You’re viewing 5 of 11 investors. Get the full list »

MxT Biotech FAQs

  • When was MxT Biotech founded?

    MxT Biotech was founded in 2021.

  • Where is MxT Biotech headquartered?

    MxT Biotech is headquartered in Seoul, South Korea.

  • What is the size of MxT Biotech?

    MxT Biotech has 16 total employees.

  • What industry is MxT Biotech in?

    MxT Biotech’s primary industry is Discovery Tools (Healthcare).

  • Is MxT Biotech a private or public company?

    MxT Biotech is a Private company.

  • What is MxT Biotech’s current revenue?

    The current revenue for MxT Biotech is .

  • How much funding has MxT Biotech raised over time?

    MxT Biotech has raised $4.01M.

  • Who are MxT Biotech’s investors?

    IBK Changgong, Tech Incubator Program for Startup, BNK Venture Capital, DAYLI Partners, and Hyundai Investment Partners are 5 of 11 investors who have invested in MxT Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process